HAMAD MEDICAL CORPORATION
🇶🇦Qatar
"Palivizumab Therapy for RSV-bronchiolitis"
Phase 3
Completed
- Conditions
- Respiratory Syncytial Virus-bronchiolitis
- Interventions
- Other: Placebo
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2018-02-27
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 420
- Registration Number
- NCT02442427
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management
Phase 4
Completed
- Conditions
- Renal ColicUrinary Calculi
- Interventions
- First Posted Date
- 2014-07-11
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 1645
- Registration Number
- NCT02187614
- Locations
- 🇶🇦
Emergency Department, Hamad General Hospital., Doha, Qatar
Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis
Phase 2
Completed
- Conditions
- BronchiolitisMagnesium, Abnormal Blood Level
- Interventions
- Other: placebo
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2016-08-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT02145520
- Locations
- 🇶🇦
Pediatric Emergency Center, Al Saad, Doha, Qatar
Comparison Among Erythropoietin Stimulating Agents
Phase 4
Completed
- Conditions
- Anemia of End Stage Renal Disease
- Interventions
- Drug: Epoetin alpha or beta (Epoetin group)
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2017-09-13
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 327
- Registration Number
- NCT02049346
- Locations
- 🇶🇦
Fahd Bin Jassem Dialysis Centre, Doha, Qatar
The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.
Not Applicable
Completed
- Conditions
- FeverReduction in Temperature
- Interventions
- First Posted Date
- 2013-07-03
- Last Posted Date
- 2013-07-03
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 434
- Registration Number
- NCT01891435
- Locations
- 🇶🇦
Hamad medical corporation, Doha, Qatar
Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient
Phase 3
- Conditions
- RHEUMATOID ARTHRITIS
- Interventions
- Drug: Anti TNF + MethDrug: Pred + Meth
- First Posted Date
- 2012-11-09
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT01724268
- Locations
- 🇶🇦
Hamad General Hospital, Doha, Ad Dawha, Qatar
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma
- First Posted Date
- 2012-04-25
- Last Posted Date
- 2014-01-28
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 400
- Registration Number
- NCT01584726
- Locations
- 🇶🇦
Pediatric Emergency Centre, Doha, Qatar
🇶🇦Hamad Medical Corporation, Doha, Qatar
Sildenofil in Persistent Pulmonary Hypertension in Newborns
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2012-09-25
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT01558466
- Locations
- 🇶🇦
Women's hospital, NICU, Doha, Qatar
Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants
Not Applicable
Completed
- Conditions
- ApneaCaffeineBronchiolitis
- Interventions
- Drug: Normal saline
- First Posted Date
- 2011-09-16
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 90
- Registration Number
- NCT01435486
- Locations
- 🇶🇦
Pediatric emergency center, Hamad Medical Corporation, Doha, Qatar
Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations.
- First Posted Date
- 2011-07-15
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 597
- Registration Number
- NCT01395589
- Locations
- 🇶🇦
Hamad Medical Corporation, Pediatric Emergency Center,Alsaad., Doha, Qatar
© Copyright 2025. All Rights Reserved by MedPath